Is Ardelyx Inc (ardx) a good stock to buy?

Ardelyx Inc (NASDAQ: ARDX) shares rose 81.2% to $2.21 in pre-market trading as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.

What is ardx ®?

As a Woman-Owned, Minority-Owned, and Small Disadvantaged Business, ARDX ® has been a leading federal healthcare management and technology consulting firm for over a decade.

Is ardx trading at a 8% discount?

ARDX is trading at a 8% discount. Is it the right time to buy, sell, or hold? Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ARDX is a good fit for your portfolio.

Is ardx a homegrown success story?

Norfolk City Council member Danica Royster said ARDX was a homegrown success story. “The city consistently seeks out opportunities to lend its support to small-, women- and minority-owned businesses, including ARDX,” Royster said.